Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
BMC Bioinformatics|May 19, 2023
Accuracy of a machine learning method based on structural and locational information from AlphaFold2 for predicting the pathogenicity of TARDBP and FUS gene variants in ALSYuya Hatano, Tomohiko Ishihara, Osamu OnoderaInternal Medicine (Tokyo, Japan)|September 16, 2016
A Senile Case of Late-onset Pompe's DiseaseHiroki Takano, Tomohiko Ishihara, Motomichi Kosuga, et al.Neurology. Genetics|May 8, 2023
Machine Learning Approach for the Prediction of Age-Specific Probability of SCA3 and DRPLA by Survival Curve AnalysisYuya Hatano, Tomohiko Ishihara, Sachiko Hirokawa, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 1, 2016
Performance of a real-time PCR-based approach and droplet digital PCR in detecting human parechovirus type 3 RNAYuta Aizawa, Akihide Koyama, Tomohiko Ishihara, et al.Brain and Nerve = Shinkei Kenkyu No Shinpo|November 14, 2019
[Molecular Pathogenesis of Amyotrophic Lateral Sclerosis]Shintaro Tsuboguchi, Tomohiko Ishihara, Akihiro Sugai, et al.Rinsho Shinkeigaku = Clinical Neurology|December 19, 2014
[Aberration of the spliceosome in amyotrophic lateral sclerosis]Tomohiko Ishihara, Akiyoshi Kakita, Hitoshi Takahashi, et al.Brain and Nerve = Shinkei Kenkyu No Shinpo|November 27, 2009
[The implications of TDP-43 mutations in pathogenesis of amyotrophic lateral sclerosis]Tomohiko Ishihara, Akio Yokoseki, Masatoyo Nishizawa, et al.Internal Medicine (Tokyo, Japan)|March 18, 2026
Multisystemic Involvement in Autosomal Recessive Cerebellar Ataxia Type 8 Having a Novel SYNE1 Nonsense VariantShoko Hongo, Takuya Konno, Yuya Hatano, et al.Rinsho Shinkeigaku = Clinical Neurology|January 21, 2020
[Molecular mechanism of amyotrophic lateral sclerosis (ALS) from the viewpoint of the formation and degeneration of transactive response DNA-binding protein 43 kDa (TDP-43) inclusions]Sou Kasahara, Tomohiko Ishihara, Yuka Koike, et al.Rinsho Shinkeigaku = Clinical Neurology|April 27, 2022
[ATTRv amyloidosis with early improvement demonstrated by the 6-minute walk test following Patisiran therapy: a case report]Shinya Oginezawa, Tomohiko Ishihara, Yohei Iwafuchi, et al.Pageof 6